Concepedia

Publication | Open Access

Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen

37

Citations

30

References

2023

Year

Abstract

ClinicalTrials.gov Identifier: NCT01356290.

References

YearCitations

Page 1